Amentum Holdings, Inc.

Executive Summary

BUY, Low conviction. AMTM screens as a messy but mispriced defense and government-services turnaround. The market is focused on the FY26 revenue cut to $13.8B-$13.95B and the 3% FY27 NASA headwind, but management simultaneously raised EBITDA and EPS guidance, delivered eight straight EPS beats, and reached 3.0x net leverage early after $125M of debt paydown. At $20.31, down 46.7% from the $38.11 high and 23.2% below the 200-day average, the stock already discounts a lot of the revenue noise.

Investment Thesis

The stock is interesting because reported FY2025 numbers look bad enough to scare off most buyers, but the current earnings power looks much better than those trailing figures suggest. FY2025 revenue jumped to $14.4B, but reported EPS fell to $0.27, operating margin compressed to 2.8%, and net margin was -0.8%. On those optics alone, the shares deserve skepticism. The opportunity is that management's latest guidance points to a different business than the one trailing GAAP metrics describe: FY26 adjusted EBITDA of $1.115B-$1.14B, adjusted EPS of $2.40-$2.50, and FCF of $525M-$575M. That is not a story of booming sales. It is a story of better mix, better execution, and better cash conversion.

The market's main objection is valid. Revenue was cut to $13.8B-$13.95B, and management now expects a ~$175M FY26 headwind from protested awards and corrective actions. On top of that, NASA in-sourcing is now expected to create a 3% FY27 revenue impact. Those are not cosmetic issues. They explain why conviction should stay low. But the stock at $20.31, down 46.7% from the $38.11 high, already reflects a lot of that pain. What the market may still be underpricing is the company's ability to protect profit even when revenue slips. Management explicitly raised FY26 margin expectations to 8.1% at the midpoint, 40 bps above FY25 actuals, and said the NASA impact is less severe on EBITDA than on revenue.

The case depends on three things. First, backlog must keep converting. The latest quarter still showed 1.1x book-to-bill and $48B backlog, up from $45B on the 2024 Q4 call, which says customer demand has not broken. Second, cash flow must finally show up in a way that de-risks the balance sheet. FY2025 FCF was only $0.1B, but FY26 guidance for $525M-$575M and the recent $125M debt repayment are the real proof points to watch. Third, the margin story must remain credible. The company has now delivered 8 straight EPS beats, suggesting real discipline in cost, mix, and estimate control.

What keeps conviction from moving higher is simple: this is still a low-margin, protest-prone government services contractor with Debt/EBITDA 3.88 and weak historical cash-flow quality. If the raised earnings and cash guidance holds through the next two quarters, the stock is too cheap. If revenue disruption broadens beyond NASA and protested awards, the market will keep treating AMTM as a value trap.

Key Metrics

Financial Strength

The balance sheet is workable, not clean. Leverage remains elevated for a business with thin reported margins, with Debt/EBITDA at 3.88 and $3.8B of total debt, but the direction has improved as better-than-expected cash generation supported $125M of repayment and early achievement of 3.0x net leverage on management's internal measure. The real tension is between weak historical cash conversion, with just $0.1B of FY2025 FCF, and a much stronger FY26 outlook of $525M-$575M. If that conversion comes through, AMTM's balance sheet moves from concern to manageable quickly. If it does not, leverage stays a valuation cap.

Competitive Position

AMTM's moat comes from incumbency in mission-critical federal contracts, a large base of specialized engineering and cleared talent, and the friction customers face in switching providers on regulated, long-duration programs. That moat is real but not impregnable: recompete and protest dynamics can delay revenue, and agency insourcing can claw back work, as shown by the 3% FY27 NASA impact. The durability looks moderate, supported by $48B backlog, but returns depend on execution because the business does not enjoy software-like margins.

Management & Guidance

Current guidance is mixed but more credible than the headline revenue cut suggests. Management explicitly acknowledged the problem, with CFO Travis Johnson saying, "We now expect revenue between $13.8 billion and $13.95 billion, with reduced contributions from new business awards under protests and our latest expectations on materials and nonlabor volume." At the same time, the company raised profit and cash expectations, with Johnson adding, "As a result of our strong year-to-date performance, we are raising our outlook for adjusted EBITDA to between $1.115 billion and $1.14 billion, reflecting adjusted EBITDA margins of 8.1% at the midpoint, a 20 basis point improvement from our prior guidance and a 40 basis point increase from fiscal year '25 actuals." Given the 8 straight EPS beats and the fact that recent profit has outperformed revenue, that guidance deserves some credit, though not full trust because protested awards and the 3% FY27 NASA impact remain outside management's control.

Segment Analysis

• Total company ($14.4B FY2025 revenue): Scale is large, but reported profitability is thin; current thesis leans on margin and cash improvement rather than pure sales growth.
• NASA-related work (~3% FY27 revenue impact): Management now expects NASA in-sourcing to reduce FY27 revenue by 3%; EBITDA impact should be less severe because the affected work is margin accretive.
• Remaining portfolio ex-NASA (Majority of revenue): Management expects mid-single-digit growth here in FY27, enough to more than offset NASA and the exit of ~1% of revenue in low/no-margin base operations.
• Savannah River project (> $1B lifetime revenue opportunity): Management flagged this as a meaningful nuclear-growth program with economics consistent with a 2-gigawatt nuclear project.

Capital Allocation

Capital allocation is currently about repair, not return. FY2025 showed $0.0B in buybacks, $0.0B in dividends, and $0.0B in capex, while recent cash outperformance funded $125M of debt repayment. That is the right call with $3.8B of debt and Debt/EBITDA 3.88. If management delivers FY26 FCF of $525M-$575M, balance-sheet improvement should remain the first use of cash.

Management Execution & Track Record

Management's record since the 2024 Q4 call is better on profit, cash, and leverage than on revenue timing. Back then, the company guided FY25 revenue to $13.8B-$14.2B, adjusted EBITDA to $1.06B-$1.10B, adjusted EPS to $2.00-$2.20, FCF to $475M-$525M, and net leverage to roughly 3.0x by FY26 end. Today, FY26 revenue has slipped to $13.8B-$13.95B because of protested awards and lower materials volume, but adjusted EBITDA has moved up to $1.115B-$1.14B, adjusted EPS to $2.40-$2.50, and FCF to $525M-$575M, while the company says it reached 3.0x net leverage early after $125M of paydown. The sequence of 8 straight EPS beats reinforces that this team has managed costs and mix better than it has controlled award timing. Strategy has not changed materially: the same playbook of integration, centers of excellence, margin discipline, and backlog conversion remains in place, but the growth cadence from new awards has been slower than management hoped in late 2024.

Positioning & Flows

Ownership is tight, with the top institutions at 75.8% and insiders at 20.0%, which limits true float and can amplify moves when sentiment changes. Short interest is noticeable at 10.65M shares, 5.41% of float, with 5.4 days-to-cover, though it has fallen 14%, suggesting some bears have already reduced exposure. Options positioning is mildly supportive: the positive GEX regime and zero-gamma at $18.14, about 11.08% below spot, imply less unstable downside trading unless fundamentals deteriorate again.

Bull Case

• Management cut revenue but raised profits, now guiding adjusted EBITDA to $1.115B-$1.14B and saying margins should be 8.1% at the midpoint, 20 bps above prior guidance and 40 bps above FY25 actuals.
• Execution has been consistent: AMTM has posted 8 straight EPS beats, from +88.0% in 2024-12-16 to +9.7% on 2026-08-10, which supports confidence in cost control and estimate management.
• Backlog improved from $45B on the 2024 Q4 call to $48B now, with funded backlog up 10% YoY and current 1.1x book-to-bill, despite procurement protests slowing award timing.
• Balance-sheet risk is moving the right way. Management used stronger cash generation to repay $125M of debt and hit 3.0x net leverage early, ahead of the prior plan to get near that level by FY26 end.

Bear Case

• FY2025 reported economics were weak, with EPS of $0.27, operating margin of 2.8% versus 3.5% prior year, and net margin of -0.8%, so the investment case depends heavily on adjusted earnings and future conversion rather than trailing GAAP profits.
• Management cut FY26 revenue guidance to $13.8B-$13.95B and identified a ~$175M headwind from delayed awards, especially protested bids and corrective actions, showing growth is still hostage to procurement timing.
• NASA in-sourcing now creates a 3% FY27 revenue impact, worse than prior expectations, and that is a real hole the rest of the portfolio must outgrow.
• Leverage is still not trivial for a low-margin contractor, with Debt/EBITDA at 3.88, total debt of $3.8B, and only $0.1B of FY2025 FCF actually reported.

Valuation & Price Target

Engine price target $29.42 (+44.9% vs current), Low confidence.

• P/E Multiple: $19.47 (28% weight)
• PEG (growth-adjusted): $63.49 (5% weight)
• P/S Multiple: $158.97 (1% weight)
• Quality-adjusted: $21.06 (20% weight)
• DCF: $112.21 (1% weight)

This call aligns with the quant baseline of BUY, but with the same Low conviction tag for good reason. The engine's $29.42 target sits above the current $20.31, yet the valuation methods are noisy: P/S at $158.97 and DCF at $112.21 are not decision-useful for a low-margin government contractor, while peers have wide dispersion of 4.1x around an average P/E of 25.5. The practical support for a BUY is simpler: the stock trades near peer trailing P/E at 24.65x despite much weaker recent sentiment, but forward earnings power of $2.40-$2.50, improving EBITDA margins, and a path to stronger FCF make the current price look too depressed. Analyst consensus is also Buy, but that is low-signal context only and not the basis of the rating.

Risk Assessment

Risk score 34/100 (Low). The biggest risk is that procurement delays and the 3% FY27 NASA revenue hit combine with still-elevated leverage of Debt/EBITDA 3.88 to prevent the expected earnings and cash-flow step-up from showing up in reported results.

The Bottom Line

Rated BUY, Low conviction. The setup is attractive because the stock is trading like a broken government contractor while guidance points to rising earnings, stronger free cash flow, and ongoing deleveraging. The discount is deserved in part because revenue visibility has slipped and reported FY2025 profitability was poor. Even so, at $20.31 and nearly 47% below the high, the market appears too focused on sales delays and not focused enough on the company's improving earnings power and backlog support. This view would turn more cautious if FY26 free cash flow misses the $525M-$575M range or if non-NASA growth fails to offset the announced 3% FY27 revenue hit.